EPRX
Eupraxia Pharmaceuticals
EPRX
EPRX
35 hedge funds and large institutions have $104M invested in Eupraxia Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8.32% less ownership
Funds ownership: 35.63% → 27.31% (-8.3%)
Holders
35
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.39M | |
| 2 | +$3.76M | |
| 3 | +$1.71M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.28M |
| 5 |
SC
SummitTX Capital
Fort Worth,
Texas
|
+$1.08M |
Top Sellers
| 1 | -$5.31M | |
| 2 | -$3.19M | |
| 3 | -$2.15M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.48M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.43M |
